EUVIMEDOpdag EUVIMED
Crossref

Drug–Drug Interaction Prediction: Paradigm Shifts, Key Bottlenecks, and Future Directions

Xiaoqing Ru, Zhen Li, Leyi Wei, Yuanan Liu, Quan Zou

WIREs Computational Molecular Science · 2025-11 · 15 (6)

DOI: 10.1002/wcms.70056 ↗

At a glance

Journal article in WIREs Computational Molecular Science, published online on 2025-11-09. Written by Xiaoqing Ru and 4 co-authors. Cited 8 times so far (Crossref); 124 references. Funded by: National Natural Science Foundation of China.

AbstractBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Polypharmacy has become a routine practice in modern medicine, yet the risks of drug–drug interactions (DDIs) remain a critical challenge for patient safety. Given the vast number of possible drug combinations and the impracticality of exhaustive clinical testing, computational approaches have become indispensable for DDI prediction. Over the past 15 years, the field has shifted from handcrafted, similarity‐based models to deep learning and graph neural networks (GNNs). Prediction tasks have also expanded from binary classification to multi‐class, multi‐label, cold‐start, and higher‐order settings. These reflect an emerging paradigm in both methodology and scope. Yet critical bottlenecks remain. Data sparsity, unreliable negatives, class imbalance, and source heterogeneity undermine robustness; models still struggle with generalization to unseen drugs, with mechanistic interpretability, and with capturing asymmetric or higher‐order interactions. These limitations continue to impede translation into clinical and regulatory practice. In this Advanced Review, we critically assess methodological evolution, benchmark datasets, and emerging paradigms, including GNNs, large language models (including multimodal extensions), and generative AI, and examine their promises and limitations. We argue that next‐generation progress hinges on unified multimodal and mechanism‐aware frameworks, strategies for robust learning under cold‐start and long‐tail scenarios, and the integration of causal inference with generative approaches to enhance interpretability. By synthesizing past advances with forward‐looking perspectives, this review outlines strategic pathways for accelerating the transition of DDI prediction toward intelligent, interpretable, and clinically actionable solutions. This article is categorized under: Data Science > Artificial Intelligence/Machine Learning Data Science > Chemoinformatics Molecular and Statistical Mechanics > Molecular Interactions

Funding

  • National Natural Science Foundation of China

Cite

APA

Ru, X., Li, Z., Wei, L., Liu, Y., & Zou, Q. (2025). Drug–Drug Interaction Prediction: Paradigm Shifts, Key Bottlenecks, and Future Directions. WIREs Computational Molecular Science, 15(6). https://doi.org/10.1002/wcms.70056

Vancouver

Ru X, Li Z, Wei L, Liu Y, Zou Q. Drug–Drug Interaction Prediction: Paradigm Shifts, Key Bottlenecks, and Future Directions. WIREs Computational Molecular Science. 2025;15(6). doi:10.1002/wcms.70056

BibTeX
@article{Ru2025,
  author = {Ru, Xiaoqing and Li, Zhen and Wei, Leyi and Liu, Yuanan and Zou, Quan},
  title = {Drug–Drug Interaction Prediction: Paradigm Shifts, Key Bottlenecks, and Future Directions},
  journal = {WIREs Computational Molecular Science},
  year = {2025},
  volume = {15},
  number = {6},
  doi = {10.1002/wcms.70056}
}
Start for free →